Wellness

  • Science edges towards breakthrough in male contraception

    After decades of women carrying contraceptive responsibility, advancements in the development of male contraceptives could see products approved for use within the next few years, with the potential to shift the burden of birth control. For all the freedoms that come with it, for decades, women have borne the brunt of the responsibility for birth [...]

  • UCL spin-out raises £2.5m to improve infant health with breast milk microbiome

    London-based biotechnology company BoobyBiome has raised £2.5m in seed funding for its infant feeding solutions. The funding round was led by specialist deep tech investor Empirical Ventures, alongside The Helm, XFactor Ventures, Lavender Ventures, Kayan Ventures, and Evenlode Investment, with influential angels including Dominic Hollamby, Lord Ara Darzi, Yael Cohen, Vanessa Colomar, and others. Founded [...]

  • NHS rolls out new generation ‘artificial pancreas’ to help pregnant diabetic women

    Thousands of pregnant women in England with type 1 diabetes will receive a pregnancy-specific artificial pancreas to help manage blood glucose and protect maternal and baby health. The hybrid closed loop system combines an insulin pump, glucose sensor and mobile phone algorithm. It calculates and delivers insulin around the clock, and uniquely allows women to [...]

  • Researchers call for targeted menopause support for autistic women

    Autistic women face serious gaps in menopause support and healthcare, with many reporting poor treatment and a lack of tailored information, a new review shows. The analysis found many were unaware of symptoms when they began, struggled to access appropriate care and often had negative experiences with health services. Three main issues emerged: poor knowledge [...]

  • Sara Davies to Open Women’s Health Week Europe 2025

    Sara Davies, acclaimed TV broadcaster and trailblazing entrepreneur, will be joining Women’s Health Week Europe as a guest speaker to open the main event at Women’s Health Week Europe this October. The announcement marks a significant moment for women’s health innovation, as one of the UK’s most recognisable investors steps onto the WHW stage to spotlight the [...]

  • Weight-loss jabs may worsen bone health in menopausal women

    Experts warn weight-loss jabs such as Wegovy and Mounjaro could worsen bone health in menopausal women already at risk of osteoporosis. Dr Jack Mosley, son of the late broadcaster and health advocate Michael Mosley, said the treatments may carry hidden side-effects for women with fragile bones. The drugs mimic GLP-1, a natural hormone that increases [...]

  • Whooping cough claims baby’s life after unvaccinated pregnancy

    A baby has died from whooping cough after the mother did not receive the vaccine during pregnancy, the UK’s first infant death from the infection this year. The death occurred between January and June 2025, according to the UK Health Security Agency (UKHSA), as vaccine uptake continues to fall among pregnant women and children. Whooping [...]

  • Round up: £1m for women’s health research and care

    Femtech World explores the latest business developments in women’s health. Portfolia launches women's health fund Investing fund Portfolia has launched the Women's Health Fund IV for women's health innovation. The company has stated that Fund IV's debut investment is in Gameto, a clinical-stage biotechnology company reprogramming female cells to transform fertility and hormonal care. [...]

  • MIT initiative will ‘give women’s health the attention it deserves’

    A new US$10m fund will back research into how the uterus affects immune function and why women face higher risks of chronic disease. The Fairbairn Menstruation Science Fund, launched by the MIT Health and Life Sciences Collaborative (MIT HEALS), is supported by a donation from philanthropists Emily and Malcolm Fairbairn. It will explore links between [...]

  • Women warned against spending money on ‘unnecessary’ menopause services

    Women going through the menopause are being cautioned against spending money on direct-to-consumer menopause services that may provide little benefit. A group of doctors raised concerns about overstated hormone therapy claims, aggressive promotion of supplements and tests, and marketing presented as advocacy. They argue that commercial menopause services raise questions about reliability and the risk [...]